Semax for Stroke Recovery & Cognitive Enhancement (NOT FDA-Approved) — Brain
Russian-approved prescription medication for stroke recovery and cognitive disorders. NOT FDA-approved. Best evidence for stroke; limited evidence for nootropic use in healthy adults.
Overview
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from ACTH(4-10), developed in Russia in the 1980s. REGULATORY: Approved in Russia and on Russian List of Vital & Essential Drugs (Dec 2011). NOT FDA-approved in US or most Western countries. BEST EVIDENCE: Stroke recovery - multiple RCTs (n=110+ patients total) showing increased BDNF, improved motor function, and faster recovery. COGNITIVE ENHANCEMENT: Limited evidence - one study showed 30% improved attention in healthy volunteers, but most studies are in Russian with limited Western validation. Mechanism: Enhances BDNF (20-24hr duration from Pro-Gly-Pro modification), activates neurotrophin transcription. PRACTICAL: Convenient intranasal administration (vs IV Cerebrolysin). SAFETY: Excellent profile from decades of Russian use - no addiction, withdrawal, or major side effects. Better evidence than BPC-157/TB-500/Dihexa but less rigorous than FDA-approved therapies.
Indications
- Stroke recovery and rehabilitation (BEST EVIDENCE - multiple Russian RCTs)
- Transient ischemic attack (TIA) recovery (Russian approved indication)
- Memory and cognitive disorders (Russian approved indication)
- Cognitive enhancement in healthy adults (LIMITED EVIDENCE - mostly Russian studies)
- Neuroprotection from ischemic damage (mechanism established)
- Age-related cognitive decline (little evidence for prevention)
Mechanism of Action
Reduced BDNF production, oxidative stress, or aging impairs focus, memory, and mental clarity
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Semax 0.1% | 100-200 mcg (1 drop per nostril) | Once or twice daily | Start low for 5-10 days to assess tolerance |
| Semax 0.1% | 200-300 mcg (1-2 drops per nostril) | 1-2 times daily | Optimal cognitive enhancement, effects last 2-4 hours |
| N-Acetyl Semax | 200-300 mcg | Once or twice daily | Extended duration (6-12 hours), more stable formulation |
| Semax 1% | Higher doses under supervision | Per medical protocol | For stroke recovery, TBI rehabilitation - medical supervision required |
Evidence Grade
GRADE C
Safety & Contraindications
- ✅ Excellent safety profile from decades of Russian clinical use
- ✅ No addiction, no withdrawal, minimal drug interactions
- ⚠️ NOT FDA-approved in US or most Western countries
- Common: Mild nasal irritation (~10% of users)
- Rare: Slight blood glucose rise (monitor if diabetic)
- Contraindicated: Pregnancy, breastfeeding, under 18, acute psychosis, recent hemorrhagic stroke
- Long-term data limited - cycling recommended (5-14 days on, 1-3 months off)
- Most evidence is Russian with limited Western validation